Stoke Therapeutics STOK
NASDAQ STOK
$25.62 -0.39 (-1.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Price to FCF (2025)

Updated

Stoke Therapeutics' (STOK) Price to FCF came in at 41.64 for Q4 2025, up 68.3% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Price to FCF (2025) Analysis & Trends

Since Q1 2025, Stoke Therapeutics has reported Price to FCF for 4 quarters.

  • According to Business Quant data, Price to FCF for the three prior quarters was 24.74 (Q3 2025), 10.16 (Q2 2025) and 5.25 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Stoke Therapeutics 1.60 Bn 429.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 41.64
Sep 30, 2025 24.74
Jun 30, 2025 10.16
Mar 31, 2025 5.25
API Access

Stoke Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=STOK&period=max&api_key=YOUR_API_KEY